Susquehanna International Group, LLP Better Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 16, 2023	SELL	$0.64 - $1.45 $27,712 - $62,785	-43,300 Reduced 54.19%	36,600 $25,000
Q4 2022 Feb 14, 2023	SELL	$1.1 - $1.74 $64,240 - $101,616	-58,400 Reduced 42.23%	79,900 $87,000
Q3 2022 Nov 14, 2022	BUY	$1.53 - $2.77 $62,118 - $112,462	40,600 Added 41.56%	138,300 $243,000
Q2 2022 Aug 15, 2022	BUY	$0.91 - $2.34 $39,858 - $102,492	43,800 Added 81.26%	97,700 $152,000
Q1 2022 May 16, 2022	SELL	$1.98 - $5.01 $69,498 - $175,851	-35,100 Reduced 39.44%	53,900 $107,000
Q4 2021 Feb 14, 2022	BUY	$4.58 - $17.14 $407,620 - $1.53 Million	89,000 New	89,000 $414,000

Ticker BTTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,743,000
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.